15 dk gecikmeli
ASELS 348,75 %0,00ASTOR 197,50 %6,81AKBNK 68,15 -%1,59YKBNK 35,66 -%2,57TUPRS 392,25 %3,29THYAO 284,25 -%0,70ISCTR 12,79 -%1,39KCHOL 212,40 %1,34BIMAS 401,00 %1,71TRALT 42,24 %2,18KTLEV 7,28 %9,97SASA 1,88 %1,62SAHOL 88,75 %1,31KLRHO 13,66 -%8,81GARAN 128,50 -%1,08GENIL 4,25 %9,82CITAS 124,20 -%2,28EREGL 36,60 %0,22EKGYO 19,61 %0,05KRDMD 43,02 %0,23TCELL 100,20 %0,80PETKM 20,64 %2,69MIATK 28,72 -%1,24VAKBN 33,66 -%0,06
RVTY logo

RVTY hisse senedi

Revvity Inc.

ABDSağlık ve İlaç

148,39USD

-5,21 (-%3,39)

8 Ekim 2026 17:46 · gecikmeli

Gün Aralığı
149,25 – 156,01
Hacim (adet)
27.107
Piyasa Değeri
13,87 milyar USD
F/K
59,58

RVTY Aylık Getiriler

Ay sonu kapanışlarına göre, USD

YılOcaŞubMarNisMayHazTemAğuEylEkiKasAraToplam
202612,5-9,6-10,9-1,120,76,41,114,418,80,3——%58,45
202513,0-11,1-5,7-11,7-3,27,0-9,12,5-2,76,811,6-7,3-%13,31
2024-1,92,2-4,2-2,46,6-4,019,8-2,44,3-7,2-2,1-3,9%2,10
2023-1,9-9,47,0-2,1-11,63,03,5-4,8-5,4-25,27,323,0-%22,04
2022-14,44,3-2,9-16,02,1-5,07,7-11,8-10,911,04,60,4-%30,26
2021——————————3,010,4%13,66
En İyi AyAra 2023 · %22,96
En Kötü AyEki 2023 · -%25,16
Ortalama Aylık%0,22
Pozitif Ay29 / 60

Günlük Fiyat Verileri

USD · en yeni en üstte

TarihAçılışEn YüksekEn DüşükKapanışDeğişimHacim
16.02.2024103,66104,35102,35102,46-%1,55466.600
15.02.2024103,84105,82103,17104,07%0,49724.200
14.02.2024102,04103,64101,92103,56%2,18660.700
13.02.2024102,90103,84100,16101,35-%3,37949.100
12.02.2024103,76105,66103,43104,89%1,09694.200
09.02.2024103,18104,27102,86103,76%0,49612.400
08.02.2024102,10103,46100,73103,25%0,34774.500
07.02.2024104,48104,48102,38102,90-%1,27880.200
06.02.2024103,77105,85103,09104,22%0,311,09 milyon
05.02.2024105,08105,79103,48103,90-%1,631,16 milyon
02.02.2024108,79108,79104,19105,62-%3,331,37 milyon
01.02.2024108,50110,00102,16109,26%1,941,43 milyon
31.01.2024111,33111,33107,00107,18-%3,601,52 milyon
30.01.2024109,62112,00109,62111,18%1,00990.200
29.01.2024110,15110,82108,93110,08%0,07771.400
26.01.2024110,66111,67109,97110,00%1,21972.400
25.01.2024108,00109,33107,24108,69%1,66812.400
24.01.2024108,23108,90105,99106,91-%0,54727.400
23.01.2024107,79108,00105,77107,49%0,731,47 milyon
22.01.2024107,79107,98106,68106,71%0,26629.900
19.01.2024106,27106,78104,79106,43%0,48627.900
18.01.2024105,89106,64104,93105,92%0,16607.900
17.01.2024107,43108,37105,22105,75-%2,26908.300
16.01.2024109,01109,45107,94108,19-%2,36788.900
12.01.2024111,77112,24110,27110,80-%0,03393.700
11.01.2024111,12112,08109,77110,83-%0,76718.100
10.01.2024109,74112,31108,53111,68%0,38806.500
09.01.2024111,34115,00109,83111,26%2,061,04 milyon
08.01.2024106,82109,78106,47109,01%1,54624.500
05.01.2024106,60109,11105,74107,36-%0,33453.900
04.01.2024105,69108,11105,58107,72%2,57756.600
03.01.2024109,81109,81104,64105,02-%4,90706.200
02.01.2024108,89111,56108,14110,43%1,02622.200
29.12.2023110,20111,26108,88109,31-%1,32385.100
28.12.2023110,94111,41109,92110,77%0,07360.900
27.12.2023109,72111,33109,45110,69%0,96673.300
26.12.2023107,98110,17107,72109,64%1,79898.300
22.12.2023106,70109,46106,66107,71%1,841,10 milyon
21.12.2023104,81107,41104,28105,76%1,64975.500
20.12.2023104,71107,64103,82104,05-%0,651,08 milyon
19.12.2023101,78105,27101,35104,73%3,371,18 milyon
18.12.2023102,05103,35100,26101,32%0,16969.300
15.12.2023102,33102,69100,22101,16-%0,151,81 milyon
14.12.202399,50102,5099,19101,31%2,671,92 milyon
13.12.202389,6298,8789,4498,68%10,311,94 milyon
12.12.202390,9390,9388,9089,46-%1,36726.900
11.12.202390,9791,4790,0890,69-%0,36628.300
08.12.202391,4392,4090,3791,02-%0,72550.500
07.12.202390,6791,7390,2591,68%1,15666.200
06.12.202389,9992,0289,2490,64%1,44505.000
05.12.202391,1591,1588,6289,35-%2,63483.400
04.12.202390,5792,6190,5791,76%0,53515.300
01.12.202388,7291,3087,5891,28%2,68720.700
30.11.202389,4189,6487,8588,90-%0,57993.600
29.11.202388,5189,8388,2689,41%1,89500.900
28.11.202388,2788,3586,3087,75-%0,57438.500
27.11.202389,4389,6688,2188,25-%2,04432.800
24.11.202389,1990,0988,7990,09%0,68149.200
22.11.202389,7190,1288,9089,48%0,63322.700
21.11.202389,8190,8488,7888,92%0,91519.600

Yabancı HisselerABDSağlık ve İlaçUSD